News

The 6^th ESMO Sarcoma & GIST Conference, 16-17 February 2016, will be held once again in Milan, Italy. 

New research shows even moderate exercise can help regain the ability to do everyday tasks and have a significant impact on QoL

The new programme, to start within four months, will crossmatch the tumours of individual ­patients with cancer drugs already on the market.

Wolfgang Wick explains the clinical importance of findings that brain metastases differ genetically from primary tumours and metastases in other organs

Approval concerns treatment of patients with unresectable and advanced liposarcoma and leiomyosarcoma

As Merkel polyomavirus-specific T cells and the expression of PD-L1 were found in the tumour cells, there is good rationale to believe that Merkel cell carcinoma might be responsive to PD-1 pathway blockade. 

Save the date and register your interest!

Indicated for patients with newly-diagnosed glioblastoma multiforme

It is intended for the reduction of hypercalcaemia in patients with parathyroid carcinoma

Researchers report that the original cancer in a patient’s body may have important differences at a genetic level from cancer that has spread to the patient’s brain

An international team of researchers has shown that the use of the mTOR inhibitor everolimus can delay tumour growth among both gastrointestinal and lung NETs

Long-term follow-up of EORTC study strongly supports adding regional hyperthermia to neoadjuvant chemotherapy